Related Experiment Video
Updated: Dec 14, 2025

03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.2K
A 79-year-old man with persistent eosinophilia and elevated immunoglobulin E
Joel P Brooks1, Kaoru Harada1, Nicole K Le1
1From the Department of Internal Medicine, Yale School of Medicine/Yale-New Haven Hospital, New Haven, Connecticut.
Allergy and Asthma Proceedings
|July 25, 2020
Summary
Eosinophilia can stem from various conditions. This case shows how targeted testing is crucial for diagnosing rare causes of persistent eosinophilia and elevated immunoglobulin E.
Area of Science:
- Immunology
- Hematology
- Internal Medicine
Background:
- Eosinophilia, an increase in eosinophils, has a broad differential diagnosis.
- Common causes include allergic reactions, infections, autoimmune disorders, and malignancies.
- Elevated immunoglobulin E (IgE) can be associated with allergic and other conditions.
Observation:
- A 79-year-old male presented with persistent eosinophilia and elevated IgE.
- Initial treatments for presumed environmental exposures did not resolve the condition.
- The patient underwent further specialized diagnostic testing.
Findings:
- Sequential and targeted investigations were essential for identifying the underlying cause.
- The case underscores the diagnostic challenges posed by rare etiologies of eosinophilia.
- Specific diagnostic pathways are critical when common causes are excluded.
Implications:
- This case emphasizes the need for a systematic approach in evaluating persistent eosinophilia.
- It highlights the importance of considering rare diagnoses beyond typical differentials.
- Clinicians should consider advanced diagnostic strategies for refractory eosinophilia and elevated IgE.
More Related Videos
Related Concept Videos
Allergic Reactions
31.6K
Overview
31.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K

